VOR peer analysis
Vor Biopharma (VOR) against its competitors: price, today's move, 1-year return and market value side by side.
VOR and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| AUTL Autolus Therapeutics | $1.30 | 3.17% | -10.64% | $367.30M |
| CRSP CRISPR Therapeutics | $49.35 | 1.63% | -14.61% | $5.02B |
| EDIT Editas Medicine | $2.57 | 0.78% | -8.45% | $417.74M |
| FATE Fate Therapeutics | $1.82 | -1.73% | 52.10% | $250.42M |
| IPSC Century Therapeutics | $1.69 | 11.59% | 162.65% | – |
| NKTX Nkarta | $1.87 | 19.10% | -19.29% | – |
| NTLA Intellia | $11.39 | 2.60% | -9.84% | $1.72B |
| RCKT Rocket Pharmaceuticals | $2.39 | -1.89% | -25.99% | $286.51M |
| SANA Sana | $2.36 | 0.85% | -41.93% | – |
| VOR Vor Biopharma | $20.20 | 8.25% | -9.78% | – |
- VOR's peers: AUTL (Autolus Therapeutics), CRSP (CRISPR Therapeutics), EDIT (Editas Medicine), FATE (Fate Therapeutics), IPSC (Century Therapeutics), NKTX (Nkarta), NTLA (Intellia), RCKT (Rocket Pharmaceuticals).
Updated 2026-11-07 11:54 UTC